Risk Factors for Cardiovascular Disease
Risk factors for cardiovascular disease are conditions or behaviors that increase your chance of developing heart-related issues, such as high blood pressure, high cholesterol, smoking, and obesity.
Roxadustat: Impact on Heart and Metabolism
We are investigating how roxadustat influences glucose and fat metabolism and heart function in participants. This study may help us understand its potential benefits for cardiovascular health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Metabolic Syndrome
Metabolic syndrome is a cluster of conditions that occur together, increasing your risk of heart disease, stroke, and diabetes. These conditions include high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 100 kg in weight?
- Do you have high blood pressure (systolic blood pressure over 150 mmHg)?
- Are you currently pregnant or breastfeeding?
- Are you taking any regular medications, like blood pressure pills or antidepressants?
- Have you had significant surgery in the past 6 months?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Pohjois-Pohjanmaan hyvinvointialue
Research Unit of Internal Medicine
Oulu, Finland
Sponsor: Pohjois-Pohjanmaan hyvinvointialue
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.